What is she best known for?
The fields of study she is best known for:
- Cancer
- Internal medicine
- Surgery
Cristina R. Ferrone mostly deals with Surgery, Internal medicine, Cancer, Cancer research and Oncology.
Her research integrates issues of Incidence, Radiology, Pancreatic disease and FOLFIRINOX in her study of Surgery.
The concepts of her Internal medicine study are interwoven with issues in Gastroenterology and Endocrinology.
Her Colorectal cancer, Metastasis and Gemcitabine study, which is part of a larger body of work in Cancer, is frequently linked to In patient, bridging the gap between disciplines.
Her Cancer research research is multidisciplinary, incorporating perspectives in Cancer cell, Pancreatic cancer, Immunology and Immunotherapy.
Her research in Oncology intersects with topics in Lymph node, MLH1, Germline mutation and Pancreatic ductal adenocarcinoma.
Her most cited work include:
- Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway (1019 citations)
- BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma (635 citations)
- Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function (565 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Internal medicine, Oncology, Surgery, Pancreatic cancer and Cancer.
Her study ties her expertise on Gastroenterology together with the subject of Internal medicine.
Her Oncology research incorporates themes from FOLFIRINOX, Disease, Lymph node, Pathology and Pancreatic ductal adenocarcinoma.
While the research belongs to areas of Surgery, she spends her time largely on the problem of Radiology, intersecting her research to questions surrounding Intrahepatic Cholangiocarcinoma.
Her Pancreatic cancer research integrates issues from Neoadjuvant therapy and Cancer research.
Her study in Cancer research is interdisciplinary in nature, drawing from both Cancer cell and Immunotherapy.
She most often published in these fields:
- Internal medicine (41.05%)
- Oncology (23.15%)
- Surgery (19.09%)
What were the highlights of her more recent work (between 2019-2021)?
- Internal medicine (41.05%)
- Pancreatic cancer (18.85%)
- Oncology (23.15%)
In recent papers she was focusing on the following fields of study:
Internal medicine, Pancreatic cancer, Oncology, Gastroenterology and Cancer are her primary areas of study.
Her Pancreatic cancer research focuses on Adenocarcinoma and how it relates to Surgical oncology.
Her Oncology study combines topics from a wide range of disciplines, such as AJCC staging system, Disease, MEDLINE and Perineural invasion.
Cristina R. Ferrone combines subjects such as Chemotherapy, Lymph node, Proportional hazards model, Hazard ratio and Survival analysis with her study of Gastroenterology.
Her Cancer research includes elements of Cancer research and Pancreas.
As part of one scientific family, Cristina R. Ferrone deals mainly with the area of Cancer research, narrowing it down to issues related to the Immunotherapy, and often Antigen.
Between 2019 and 2021, her most popular works were:
- Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer. (15 citations)
- Variation in long-term oncologic outcomes by type of cancer center accreditation: An analysis of a SEER-Medicare population with pancreatic cancer. (9 citations)
- Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma: A Bi-institutional Analysis. (9 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Her primary scientific interests are in Internal medicine, Pancreatic cancer, Cancer, Oncology and Neoadjuvant therapy.
Her research combines Gastroenterology and Internal medicine.
Her Pancreatic cancer research includes themes of Reprogramming, Pancreatectomy, Pancreaticoduodenectomy, Disease and Adenocarcinoma.
Cristina R. Ferrone does research in Cancer, focusing on Immunotherapy specifically.
Within one scientific family, she focuses on topics pertaining to MEDLINE under Oncology, and may sometimes address concerns connected to Referral, Metropolitan area, Family medicine and Medical record.
Her studies in Neoadjuvant therapy integrate themes in fields like Tumor microenvironment, Irinotecan, FOLFIRINOX and Retrospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
